Jaguar Health, Inc.
JAGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001585608
No open-market purchases or sales by Jaguar Health, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $15.9K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Jaguar Health, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- 0 vs. Q1 2023
- Shares held
- 447.8K
- +81.4K (+22.2%) vs. Q1 2023
- Total value
- $231.3K
- +$2.29K (+1.0%) vs. Q1 2023
- New holders
- 6
- 4 more added
- Sold out
- 6
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JAGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $15.9K |
| Q1 2026 | 11 | $94.2K |
| Q4 2025 | 11 | $61.4K |
| Q3 2025 | 9 | $222.9K |
| Q2 2025 | 8 | $35.2K |
| Q1 2025 | 8 | $24.6K |
| Q4 2024 | 12 | $283.4K |
| Q3 2024 | 13 | $387.1K |
| Q2 2024 | 12 | $367.0K |
| Q1 2024 | 20 | $523.7K |
| Q4 2023 | 20 | $184.4K |
| Q3 2023 | 14 | $153.2K |
| Q2 2023 | 16 | $231.3K |
| Q1 2023 | 16 | $229.0K |
| Q4 2022 | 30 | $502.9K |
| Q3 2022 | 28 | $873.0K |
| Q2 2022 | 27 | $1.74M |
| Q1 2022 | 33 | $3.94M |
| Q4 2021 | 28 | $4.75M |
| Q3 2021 | 30 | $12.8M |
| Q2 2021 | 36 | $31.9M |
| Q1 2021 | 45 | $13.7M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Jaguar Health, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 92,333 | $47.8K | 0.00% | +92,333 | New |
| Vanguard Group Inc | 79,565 | $41.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 55,985 | $28.9K | 0.00% | +13,350+31.3% | Added |
| BlackRock Inc. | 51,212 | $26.4K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 40,539 | $21.0K | 0.00% | +40,539 | New |
| Two Sigma Securities, LLC | 29,698 | $15.3K | 0.00% | −22,233−42.8% | Reduced |
| Csenge Advisory Group | 25,000 | $12.9K | 0.00% | +25,000 | New |
| JPMorgan Chase & Co | 22,983 | $11.9K | 0.00% | +21,228+1,209.6% | Added |
| Sterling Investment Advisors, Ltd. | 19,000 | $9.80K | 0.00% | +19,000 | New |
| Citadel Advisors LLC | 15,492 | $8.01K | 0.00% | +15,492 | New |
| XTX Topco Ltd | 15,007 | $7.76K | 0.00% | +15,007 | New |
| Group One Trading, L.P. | 762 | $394 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 100 | $52 | 0.00% | +88+733.3% | Added |
| UBS Group AG | 40 | $21 | 0.00% | −10,500−99.6% | Reduced |
| Farther Finance Advisors, LLC | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 43 | $0 | 0.00% | +9+26.5% | Added |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −69,346−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −35,400−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,378−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,606−100.0% | Sold out |
| Edmond de Rothschild Holding S.A. | 0 | $0 | 0.00% | −222−100.0% | Sold out |
| WR Wealth Planners, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |